Latest News and Press Releases
Want to stay updated on the latest news?
-
Yaqrit strengthens board and senior management with seasoned industry leaders. Poised to implement late stage clinical strategy in advanced liver disease.
-
EXTON, PA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Biologics have long been the cornerstone of psoriasis (PsO) treatment, valued for their proven efficacy and safety. However, the growing demand for...
-
EXTON, PA, July 18, 2024 (GLOBE NEWSWIRE) -- In February of this year, Takeda’s Eohilia (budesonide oral suspension) received FDA approval as the first and only oral therapy for eosinophilic...
-
Exton, Pennsylvania, March 22, 2024 (GLOBE NEWSWIRE) -- The end of 2023 introduced several new treatment options for patients suffering from ulcerative colitis (UC). Among them is Eli Lilly’s Omvoh...
-
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...
-
Exton, Pennsylvania, Nov. 30, 2023 (GLOBE NEWSWIRE) -- With the Ulcerative Colitis (UC) market set to heat up in the coming months, the JAK class seems poised to become a dominant treatment,...
-
Exton, Pennsylvania, Nov. 13, 2023 (GLOBE NEWSWIRE) -- In the past two months, the landscape of available treatments for ulcerative colitis (UC) has undergone a significant expansion, marked by the...
-
WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company...
-
BOSTON, Nov. 18, 2022 (GLOBE NEWSWIRE) -- A federal lawsuit was filed today in the U.S. District Court of Massachusetts against Takeda Pharmaceuticals, alleging religious discrimination. A group of...
-
Covina, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The protein which blocks thrombin is called as antithrombin. Antithrombin is the glycoprotein which is synthesized by the liver. Antithrombin inhibits the...